{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:08:58Z","timestamp":1777482538950,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1987,2,1]],"date-time":"1987-02-01T00:00:00Z","timestamp":539136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutisch Weekblad Scientific Edition"],"published-print":{"date-parts":[[1987,2]]},"DOI":"10.1007\/bf02075253","type":"journal-article","created":{"date-parts":[[2005,8,14]],"date-time":"2005-08-14T11:58:19Z","timestamp":1124020699000},"page":"S16-S22","source":"Crossref","is-referenced-by-count":5,"title":["Pharmacokinetics of the newer fluoroquinolones"],"prefix":"10.1007","volume":"9","author":[{"given":"J. R. B. J.","family":"Brouwers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02075253_CR1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01975486","volume":"8","author":"AJN Groeneveld","year":"1986","unstructured":"Groeneveld AJN, Brouwers JRBJ. Quantitative determination of ofloxacin, ciprofloxacin, norfloxacin and pefloxacin in serum by HPLC. Pharm Weekbl [Sci] 1986;8:79\u201384.","journal-title":"Pharm Weekbl [Sci]"},{"key":"BF02075253_CR2","first-page":"338","volume":"A261","author":"W Sch\u00f6nfeld","year":"1986","unstructured":"Sch\u00f6nfeld W, Kn\u00f6ller J, Bremm KD, Dahlhoff A, Weber B, K\u00f6nig W. Determination of ciprofloxacin, norfloxacin and ofloxacin by HPLC. Zbl Bakt Hyg 1986;A261:338\u201344.","journal-title":"Zbl Bakt Hyg"},{"key":"BF02075253_CR3","first-page":"75","volume":"11","author":"DB Jack","year":"1986","unstructured":"Jack DB. Recent advances in pharmaceutical chemistry. The 4-quinolone antibiotics. J Clin Hosp Pharm 1986;11:75\u201393.","journal-title":"J Clin Hosp Pharm"},{"key":"BF02075253_CR4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2165\/00003495-198530060-00003","volume":"30","author":"B Holmes","year":"1985","unstructured":"Holmes B, Brogden RN, Richards DM. Norfloxacin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use. Drugs 1985;30:482\u2013513.","journal-title":"Drugs"},{"key":"BF02075253_CR5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF01975476","volume":"8","author":"TB Vree","year":"1986","unstructured":"Vree TB, Wijnands WJA, Guelen PJM, Baars AM, Hekster YA. Pharmacokinetics, metabolism and renal secretion of quinolones in man. Pharm Weekbl [Sci] 1986;8:29\u201334.","journal-title":"Pharm Weekbl [Sci]"},{"issue":"Suppl C","key":"BF02075253_CR6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jac\/14.suppl_C.63","volume":"14","author":"R Wolf","year":"1984","unstructured":"Wolf R, Rudolf E, Dunkey A et al. The clinical pharmacokinetics and tolerance of enoxacin in healthy volunteers. J Antimicrob Chemother 1984;14 Suppl C:63\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"BF02075253_CR7","first-page":"14","volume-title":"Zusamenfassung der Forschungsergebnisse","author":"Enoxacin","year":"1986","unstructured":"Enoxacin: Zusamenfassung der Forschungsergebnisse. Parke Davis Comp Berlin 1986:14."},{"issue":"Suppl D","key":"BF02075253_CR8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/jac\/18.Supplement_D.71","volume":"18","author":"R Wise","year":"1986","unstructured":"Wise R, Lister D, McNulty CAM, Griggs D, Andrews JM. The comparative pharmacokinetics of five quinolones. J Antimicrob Chemother 1986;18 Suppl D:71\u201381.","journal-title":"J Antimicrob Chemother"},{"key":"BF02075253_CR9","first-page":"151","volume-title":"Les nouvelles quinolones","author":"C Brun Buisson","year":"1985","unstructured":"Brun Buisson C, Wolff M, Garaud JJ. Pharmacocin\u00e9tique des nouvelles quinolones. In: \u201cLes nouvelles quinolones\u201d, Ed. JJ Pocidalo, F Vachon, B Regnier. Amette Publications Paris 1985:151\u20139."},{"key":"BF02075253_CR10","unstructured":"Weidekamm E, Stoeckel K, Dell D. Single dose pharmacokinetic of the new fluoroquinolones Ro 23-6240 (AM 833) in man (abstract). Int Symp New Quinolones Geneva Switserland July 17\u201319. Abstractbook 1986:83."},{"key":"BF02075253_CR11","first-page":"83","volume-title":"Les nouvelles quinolones","author":"E Singlas","year":"1985","unstructured":"Singlas E, Taburet AM. Pharmacokin\u00e9tique clinique des nouvelles quinolones. In: \u201cLes nouvelles quinolones\u201d, Ed. JJ Pocidalo, F Vachon, B Regnier. Arnette Publications Paris 1985:83\u2013103."},{"key":"BF02075253_CR12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1128\/AAC.30.3.440","volume":"30","author":"GL Drusano","year":"1986","unstructured":"Drusano GL, Plaisance KI, Forest A, Standifort HC. Dose ranging study and constant infusion evaluation of ciprofloxacin. Antimicrob Agents Chemother 1986;30:440\u20133.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4A","key":"BF02075253_CR13","first-page":"97","volume":"82","author":"T Bergan","year":"1987","unstructured":"Bergan T, Thorsteinsson SB, Solberg R, Bjonskau L, Kolstad I, Johnsen S. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses. Am J Med 1987;82 (4A):97\u2013103","journal-title":"Am J Med"},{"issue":"Suppl B","key":"BF02075253_CR14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/jac\/17.suppl_B.65","volume":"17","author":"AM Frydman","year":"1986","unstructured":"Frydman AM, Le Roux Y, Lefebvre MA, Djebbar F, Foutillan JB, Gaillot J. Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteers. J Antimicrob Chemother 1986;17 Suppl B:65\u201379.","journal-title":"J Antimicrob Chemother"},{"key":"BF02075253_CR15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2165\/00003495-198733040-00003","volume":"33","author":"JP Monk","year":"1987","unstructured":"Monk JP, Campoli-Richards DM. Ofloxacin, a review of its antimicrobial activity, pharmacokinetic properties and therapeutic use. Drugs 1987, 33:346\u201391.","journal-title":"Drugs"},{"key":"BF02075253_CR16","unstructured":"Ro 23-6240 (AM 833) Long acting fluoroquinolones (oral broad spectrum antibacterial agent) Investigational Drug Brochure. Hoffmann-La Roche & Co Ltd Basle Switserland Dec 1986."},{"issue":"4A","key":"BF02075253_CR17","first-page":"119","volume":"82","author":"E Rubenstein","year":"1987","unstructured":"Rubenstein E, Seger S. Drug interactions of ciprofloxacin with other non-antibiotic agents. Am J Med 1987;82 (4A):119\u201324.","journal-title":"Am J Med"},{"key":"BF02075253_CR18","unstructured":"Schentag JJ, Sedman AJ, Wilton JH et al. Interactions between enoxacin, ranitidine and antacids. (Abstractbook p. 119, nr.256) Third European Congress of Clinical Microbiology. 11\/14 May 1987. The Hague, NL."},{"issue":"Suppl C","key":"BF02075253_CR19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jac\/14.suppl_C.75","volume":"14","author":"R Wise","year":"1984","unstructured":"Wise R, Lockly R, Webberly M, Adhami ZN. The pharmacokinetics and tissue penetration of enoxacin and norfloxacin. J Antimicrob Chemother 1984;14 Suppl C:75\u201381.","journal-title":"J Antimicrob Chemother"},{"key":"BF02075253_CR20","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/jac\/14.6.647","volume":"14","author":"R Lockly","year":"1984","unstructured":"Lockly R, Wise R, Dent J. The pharmacokinetics and tissue penetration of ofloxacin. J. Antimicrob Chemother 1984;14:647\u201352.","journal-title":"J. Antimicrob Chemother"},{"issue":"Suppl B","key":"BF02075253_CR21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jac\/17.suppl_B.93","volume":"17","author":"P Dellamonica","year":"1986","unstructured":"Dellamonica P, Bernard E, Etesse H, Garrafto R. The diffusion of pefloxacin into bone and the treatment of osteomyelitis. J Antimicrob Chemother 1986;17 Suppl B:93\u2013102.","journal-title":"J Antimicrob Chemother"},{"key":"BF02075253_CR22","first-page":"1417","volume":"36","author":"H Tanimura","year":"1986","unstructured":"Tanimura H, Tominaga S, Rai F, Matsumoto H. Transfer of ciprofloxacin to bile and determination of biliary metabolites in humans. Arzneimittelforsch 1986;36:1417\u201320.","journal-title":"Arzneimittelforsch"},{"key":"BF02075253_CR23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/BF02075716","volume":"5","author":"K Borner","year":"1986","unstructured":"Borner K, Lode H, H\u00f6ffken G. Renal elimination of sulfociprofloxacin a new metabolite of ciprofloxacin. Eur J Clin Microbiol 1986;5:476.","journal-title":"Eur J Clin Microbiol"},{"issue":"Suppl 1","key":"BF02075253_CR24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/BF01645200","volume":"14","author":"K Borner","year":"1986","unstructured":"Borner K, Lode H. Biotransformation von ausgew\u00e4hlten Gyrasehemmern. Infection 1986;14 Suppl 1:54\u20139.","journal-title":"Infection"},{"key":"BF02075253_CR25","first-page":"7","volume":"2","author":"T Bergan","year":"1986","unstructured":"Bergan T. Dosage regimens of quinolones in reduced renal function. Quinolones Bulletin 1986;2:7\u201310.","journal-title":"Quinolones Bulletin"},{"issue":"Suppl D","key":"BF02075253_CR26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/18.Supplement_D.83","volume":"18","author":"DS Webb","year":"1986","unstructured":"Webb DS, Roberts DE, Williams JD, Asscher AW. Pharmacokinetics in healthy volunteers and patients with impaired kidney function. J Antimicrob Chemother 1986;18 Suppl D:83\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"BF02075253_CR27","unstructured":"Fleming LW, Stewart WK, Moreland TA, Scott-AC. Pharmacokinetic studies on two day oral ciprofloxacin administration in patients on continuous ambulatory peritoneal dialysis (CAPD). Abstractbook p. 112, nr. 242. Third European Congress of Clinical Microbiology. 11\/14 May 1987. The Hague, NL Abstract (nr:242)."},{"key":"BF02075253_CR28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/clpt.1985.201","volume":"38","author":"G Danan","year":"1985","unstructured":"Danan G, Montay G, Cunci R, Erlinger S. Pefloxacin kinetics in cirrhosis. Clin Pharmacol Ther 1985;38:439\u201342.","journal-title":"Clin Pharmacol Ther"},{"key":"BF02075253_CR29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF02029528","volume":"2","author":"F DiNola","year":"1983","unstructured":"Eandi M. Viano I, DiNola F, Leone L, Genazzani E. Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage. Eur J Clin Microbiol 1983;2:253\u20139.","journal-title":"Eur J Clin Microbiol"}],"container-title":["Pharmaceutisch Weekblad Scientific Edition"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02075253.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02075253\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02075253","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T13:28:50Z","timestamp":1557840530000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02075253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,2]]},"references-count":29,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1987,2]]}},"alternative-id":["BF02075253"],"URL":"https:\/\/doi.org\/10.1007\/bf02075253","relation":{},"ISSN":["0167-6555","1573-739X"],"issn-type":[{"value":"0167-6555","type":"print"},{"value":"1573-739X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,2]]}}}